GT Biopharma, Inc.GTBPNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank21
Year-over-Year Change
Net other income and expenses outside core operations
Percentile
P21
Within normal range
vs 3Y Ago
-42.7x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-15.93M | -1425.5% |
| 2024 | $1.20M | -79.9% |
| 2023 | $5.98M | +1502.9% |
| 2022 | $373000.00 | +174.9% |
| 2021 | $-498000.00 | +97.7% |
| 2020 | $-21.53M | +20.8% |
| 2019 | $-27.19M | -198.2% |
| 2018 | $-9.12M | -6.0% |
| 2017 | $-8.60M | -144.9% |
| 2016 | $19.14M | - |